References
- AMET, Y., ADAS, F. and NANJI, A. A., 1998, Fatty acid omega- and (omega-D-hydroxylation in experimental alcoholic liver disease: relationship to different dietary fatty acids. Alcoholism: Clinical and Experimental Therapeutics, 22, 1493–1500.
- ANZENBACHER, P., SOUCEK, P., ANZENBACHEROVA, E., GUT, I., HRUBY, K., SVOBODA, Z. and KVETINA, J., 1998, Presence and activity of cytochrome P450 isoforms in minipig liver. Comparison with human liver samples. Drug Metabolism and Disposition, 26, 56–59.
- BOGAARDS, J. J. P., VAN OMMEN, B. and VAN BLADEREN, P. J., 1995, Human cytochrome P450 enzyme selectivities in the oxidation of chlorinated benzenes. Toxicology and Applied Pharmacology, 132, 44–52.
- BOGAARDS, J. J. P., VENEKAMP, J. C. and VAN BLADEREN, P. J., 1996, The biotransformation of isoprene and the two isoprene monoepoxides by human cytochrome P450 enzymes, compared to mouse and rat liver microsomes. Chemko-Biological Interactions, 102, 169–182.
- BOOBIS, A. R., SESARDIC, D., MURRAY, B. P., EDWARDS, R. J., SINGLETON, A. M., RICH, K. J., MURRAY, S., DE LA TORRE, R., SEGURA, J., PELKONEN, O., PASANEN, M., KOBAYASHI, S., ZHI-GUANG, T. and DAVIES, D. S., 1990, Species variation in the response of the cytochrome P-450-dependent monooxygenase system to inducers and inhibitors. Xenobiotka, 20, 1139–1161.
- BURKE, M. D., THOMPSON, S., WEAVER, R. J., WOLF, C. R. and MAYER, R. T., 1994, Cytochrome P450 specifities of alkoxyresorufin 0-dealkylation in human and rat liver. Biochemical Pharmacology, 48, 923–936.
- CHANG, T. K. H., GONZALEZ, F. J. and WAXMAN, D. J., 1994, Evaluation of triacetyloleandomycin, a-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochrome P450. Archives of Biochemistry and Biophysics, 311, 437–442.
- CHOLERTON, S., DALY, A. K. and IDLE, J. R., 1992, The role of individual human cytochromes P450 in drug metabolism and clinical response. TiPS Reviews, 13, 434–439.
- DALY, A. K., CHOLERTON, S., GREGORY, W. and IDLE, J. R., 1993, Metabolic Polymorphisms. Pharmacology and Therapeutics, 57, 129–160.
- DANIEL, H. I. and EDEKI, T. I., 1996, Genetic polymorphism of S-mephenytoin 4'-hydroxylation. Psychopharmacology Bulletin, 32, 219–230.
- DIRVEN, H. A. A. M., BRULIN, A. A. G. M. DE, SESSINK, P. J. M. and JONGENEELEN, F. J., 1991, Determination of the cytochrome P450 4 marker, th-hydroxylauric acid by high performance liquid chromatography and fluorometric detection. Journal of Chromatography, 564,266–271.
- EAGLING, V. A., TIIA, J. F. and BACK, D., 1998, Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. British Journal of Clinical Pharmacology, 45, 107–114.
- FORRESTER, L. M., HENDERSON, C. J., GLANCEY, M. J., BACK, D. J., PARK, B. K., BALL, S. E., KITTERINGHAM, N. R., MCLAREN, A. W., MILES, J. S., SKETT, P. and WOLF, C. R., 1992, Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochemical Journal, 281, 359–368.
- FURUYA, H., FERNANDEZ-SALGUERO, P., GREGORY, W., TABER, H., STEWARD, A., GONZALEZE, F. J. and IDLE, J. R., 1995, Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy. Pharmacogenetics, 5, 389–392.
- GHOSAL, A., SATOH, H., THOMAS, P. E., BusH, E. and MOORE, D., 1996, Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cDNA-expressed human cytochrome P450. Drug Metabolism and Disposition, 24, 940–947.
- GONZALEZ, F. J. and IDLE, J. R., 1994, Pharmacogenetic phenotyping and genotyping. Clinical Pharmacokinetics, 26, 59–70.
- GONZALEZ, F. J. and GELBOIN, H. V.,1994, Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metabolism Reviews, 26, 165–183.
- GUENGERICH, F. P., 1990, Mechanism-based inactivation of human liver microsomal cytochrome P450 IIIA4 by gestodine. Chemical Research in Toxicology, 3, 363–371.
- GUENGERICH, F. P., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4, 391–407.
- GUENGERICH, F. P., 1997, Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chemico-Biological Interactions, 106, 161–182.
- GUENGERICH, F. P., KIM, D. and IwAsmu, M., 1991, Role of human cytochrome P-450 11E1 in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology, 4, 168–179.
- GUENGERICH, F. P. and SHIMADA, T., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4, 391–407.
- GUENGERICH, F. P. and TURVEY, C. G., 1991, Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immuno - chemical analysis of surgical liver samples. Journal of Pharmacology and Experimental Thera-peutics, 256, 1189–1194.
- HONKAKOSHI, P. and NEGISHI, M., 1997, The structure, function and regulation of cytochrome P450 2A enzymes. Drug Metabolism Reviews, 29, 977–996.
- KATO, R. and YAMAZOE, Y., 1992, Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicology Letters, 64/65, 661–667.
- KIMONEN, T., JUVONEN, R. O., ALHAVA, E. and PASANEN, M., 1995, The inhibition of CYP enzymes in mouse and human liver by pilocarpine. British Journal of Pharmacology, 114, 832–836.
- KUNZE, K. L. and TRAGER, W. F., 1993, Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chemical Research in Toxicology, 6, 649–656.
- LEWIS, D. F. V., LAJE, B. G., DICKINS, M., EDDERSHAW, P. J., TARBIT, M. H. and GOLDFARB, P. S., 1999, Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b, binding site and comparisons with CYP2B1 and CYP2B4. Xenobiotica, 29, 361–393.
- LINDBERG, R. L. and NEGISHI, M., 1989, Alteration of mouse cytochrome P450,0„ substrate specificity by mutation of a single amino-acid residue. Nature, 339, 632–634.
- LUCAS, D., BERTHOU, F., DRANO, Y., LOZAC'H, P., VOLANT, A. and NUNEZ, J., 1993, Comparison of levels of cytochromes P-450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical samples. Alcoholism: Clinical and Experimental Research, 17, 900–905
- MAKOWSKA, J. M. and GIBSON, G. G., 1992, Species differences in cipofibrate induction of hepatic cytochrome P450 4A1 and peroxisome proliferation. Journal of Biochemical Toxicology, 7, 183–191.
- NAGATA, K., GONZALEZ, F. J., YAMAZOE, Y. and KATO, R., 1990, Purification and characterization of four catalytically active testosterone 6/4-hydroxylase P-450s from rat liver microsomes : comparison of a novel form with three structurally and functionally related forms. Journal of Biochemistry, 107, 718–725.
- NAKACHI, K., ImAI, K., HAYASHI, S. and KAWAJIRI, K., 1993, Polymorphisms of the CYP1A1 and glutathione S-transfera genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Research, 53, 2994–2999.
- NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., OKUDA, K. and NEBERT, D. W., 1993, The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology, 12, 1–51.
- NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN, J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, O., COON, M. J., ESTABROOK, R. W., GUNSALUS, I. C. and NEBERT, D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetks, 6, 1–42.
- NEWTON, D. J., WANG, R. W. and Lu, A. Y. H., 1995, Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154–158.
- OHMORI, S., TANIGUCHI, T., RIKIHISA, T., KANAKUBO, Y. and KITADA, M., 1993, Species differences of testosterone 16-hydroxylase in liver microsomes of guinea pig, rat and dog. Xenobiotica, 23, 419426.
- ONO, S., HATANAKA, T., HOTTA, H., SATOH, T., GONZALEZ, F. J. and TSUTSUI, M., 1996, Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica, 26, 681–693.
- PEARCE, R., GREENWAY, D. and PARKINSON, A., 1992, Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Archives of Biochemistry and Biophysics, 298, 211–225.
- PERELLA, F. W., 1988, EZ-FIT : a practical curve-fitting microcomputer program for the analysis of enzyme kinetic data on IBM-PC compatible computers. Analytical Biochemistry, 174, 437–447.
- POWELL, P. K., WOLF, I. and LASKER, J. M., 1996, Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes. Archives of Biochemistry and Biophysics, 335, 219–226.
- SCHMIDER, J., GREENBLATT, D. J., MOLTKE, L. L. VON, HARMATZ, J. S., DUAN, S. X., KARSOV, D. and SHADER, R. I., 1996, Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies. Pharmacology, 52, 125–134.
- SHARER, J. E., SHIPLEY, L. A., VANDERBRANDEN, M. R., BINKLEY, S. N. and WRIGHTON, S. A., 1995, Comparisons of phase land phase II in vitro enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metabolism and Disposition, 23, 1231–1241.
- SHARMA, R., LAKE, B. G., FOSTER, J. and GIBSON, G. G., 1988, Microsomal cytochrome P452 induction and peroxisome proliferation by hypolipidaemic agents in liver. A mechanistic inter-relationship. Biochemical Pharmacology, 37, 1193–1201.
- SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with human liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
- STEVENS, J. C., SHIPLEY, L. A., CASHMAN, J. R., VANDENBRANDEN, M. and WRIGTHON, S. A., 1993, Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities. Drug Metabolism and Disposition, 21, 753–760.
- TOMLINSON, E. S., MAGGS, J. J., PARK, B. K., AND BACK, D. J., 1997, Dexamethasone metabolism in vitro: species differences. Journal of Steroid Biochemistry and Molecular Biology, 62, 345–352.
- WEAVER, R. J., DICKINS, M. and BuRKE, M. D., 1999, A comparison of basal and induced hepatic microsomal cytochrome P450 monooxygenase activities in cynomolgus monkey (Macaca fascicularis) and man. Xenobiotica, 29, 467–482.
- WEAVER, R. J., THOMPSON, S., SMITH, G., DICKINS, M., ELCOMBE, C. R., MAYER, R. T. BURKE, M. D., 1994, A comparative study of constitutive and induced alkoxyresorufin 0-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Biochemical Pharmacology, 47, 763–773.
- WERNER, M., BIRNER, G. and DEKANT, W., 1995, The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadieny1)- L-cysteine in rats. Drug Metabolism and Disposition, 23, 861–868.
- WRIGHTON, S. A. and RING, B. J., 1994, Inhibition of human CYP3A catalyzed by 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine. Pharmaceutical Research, 6, 921–924.
- WRIGHTON, S. A. and STEVENS, J. C., 1992, The human hepatic cytochromes P450 involved in drug metabolism. Critical Reviews in Toxicology, 22, 1–21.
- YAMAZAKI, H., MIMURA, M., SUGAHARA, C. and SHIMADA, T., 1994, Catalytic roles of rat and human cytochrome P450 2A enzymes in testosterone 7- and coumarin 7-hydroxylations. Biochemical Pharmacology, 48,1524–1527.
- YASUMORI, T., CHEN, L., NAGAT, K., YAMAZOE, Y. and KATO, R., 1993, Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3 A). journal of Pharmacology and Experimental Therapeutics, 264, 89–94.